Hoffman David Andrew - Insider Non-Derivative Transactions at First Wave BioPharma, Inc. (FWBI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 3, 2023, Hoffman David Andrew's relationship to First Wave BioPharma, Inc. (FWBI) is Director, and currently has 90,778 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other FWBI insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hoffman David Andrew - Insider Non-Derivative Transactions of FWBI Common Stock

Hoffman David Andrew - Insider Non-Derivative Transactions at FWBI

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 4, 2023	Acquisition -- (Common Stock)	84745	0	90778